Impact of angiogenesis- and hypoxia-associated polymorphisms on tumor recurrence in patients with hepatocellular carcinoma undergoing surgical resection
- Weitere Titel
-
Einfluss von Angiogenese- und Hypoxie-assoziierten Polymorphismen auf das Tumorrezidiv bei Patienten mit Hepatozellulärem Karzinom, die sich einer chirurgischen Resektion unterziehen
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Rheinisch-Westfälische Technische Hochschule Aachen, Dissertation, 2021
- Schlagwort
-
Patients
Neovascularization
Liver--Cancer
Impact
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2021
- Urheber
- Beteiligte Personen und Organisationen
- DOI
-
10.18154/RWTH-2021-08589
- URN
-
urn:nbn:de:101:1-2021110502291239563313
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:49 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Miller, Hannah Kristin
- Lurje, Georg
- Strnad, Pavel
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2021
Ähnliche Objekte (12)
Impact of Angiogenesis- and Hypoxia-Associated Polymorphisms on Tumor Recurrence in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection
Angiogenesis Gene Polymorphisms as Molecular Markers to Predict Recurrence in Stage III Colon Cancer
Anti-angiogenesis in hepatocellular carcinoma treatment : current evidence and future perspectives
Genetically engineering mesenchymal stem cells for targeting tumor stroma and angiogenesis in hepatocellular carcinoma
Genetically engineering mesenchymal stem cells for targeting tumor stroma and angiogenesis in hepatocellular carcinoma
Osteopenia is associated with inferior survival in patients undergoing partial hepatectomy for hepatocellular carcinoma
Angiogenesis inhibition
Association of type 2 diabetes mellitus associated single nucleotide polymorphisms with incidence and tumor characteristics of hepatocellular carcinoma
Impact of genetic polymorphisms on the degree of ovarian response to gonadotrophin stimulation in patients undergoing ICSI treatment
Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
Impact of Body Mass Index on Tumor Recurrence in Patients Undergoing Liver Resection for Perihilar Cholangiocarcinoma (pCCA)
Imaging of angiogenesis
Impact of Angiogenesis- and Hypoxia-Associated Polymorphisms on Tumor Recurrence in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection
Angiogenesis Gene Polymorphisms as Molecular Markers to Predict Recurrence in Stage III Colon Cancer
Anti-angiogenesis in hepatocellular carcinoma treatment : current evidence and future perspectives
Genetically engineering mesenchymal stem cells for targeting tumor stroma and angiogenesis in hepatocellular carcinoma
Genetically engineering mesenchymal stem cells for targeting tumor stroma and angiogenesis in hepatocellular carcinoma
Osteopenia is associated with inferior survival in patients undergoing partial hepatectomy for hepatocellular carcinoma
Angiogenesis inhibition
Association of type 2 diabetes mellitus associated single nucleotide polymorphisms with incidence and tumor characteristics of hepatocellular carcinoma
Impact of genetic polymorphisms on the degree of ovarian response to gonadotrophin stimulation in patients undergoing ICSI treatment
Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
Impact of Body Mass Index on Tumor Recurrence in Patients Undergoing Liver Resection for Perihilar Cholangiocarcinoma (pCCA)
Imaging of angiogenesis
Impact of Angiogenesis- and Hypoxia-Associated Polymorphisms on Tumor Recurrence in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection
Angiogenesis Gene Polymorphisms as Molecular Markers to Predict Recurrence in Stage III Colon Cancer
Anti-angiogenesis in hepatocellular carcinoma treatment : current evidence and future perspectives
Genetically engineering mesenchymal stem cells for targeting tumor stroma and angiogenesis in hepatocellular carcinoma
Genetically engineering mesenchymal stem cells for targeting tumor stroma and angiogenesis in hepatocellular carcinoma
Osteopenia is associated with inferior survival in patients undergoing partial hepatectomy for hepatocellular carcinoma
Angiogenesis inhibition
Association of type 2 diabetes mellitus associated single nucleotide polymorphisms with incidence and tumor characteristics of hepatocellular carcinoma
Impact of genetic polymorphisms on the degree of ovarian response to gonadotrophin stimulation in patients undergoing ICSI treatment
Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization
Impact of Body Mass Index on Tumor Recurrence in Patients Undergoing Liver Resection for Perihilar Cholangiocarcinoma (pCCA)